Avenue Therapeutics, Inc. (ATXI) income statement
ATXIOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/30
$0.43+0.00 (0.00%)
Close on Oct 16, 2026Market cap $1.42MP/E –Yield –
Avenue Therapeutics, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2025
- Gross margin
- –
- Operating margin
- -206.3%
- Net margin
- -197.8%
- Return on equity, FY2025
- -125.7%
Financial strength
- Current ratio
- –
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 138.0%
Valuation
- P/E ratio
- –
- Price to sales
- 1.01
- Price to book
- 2.49
- Dividend yield
- –
See a number that looks wrong?